LIXTE BIOTECHNOLOGY HOLDINGS, INC. Contracts & Agreements
66 Contracts & Agreements
- Business Finance (24 contracts)
- Business Operations (10)
- Human Resources (12)
- Intellectual Property (2)
- Uncategorized (18)
- Form of Securities Purchase Agreement (Filed With SEC on November 1, 2024)
- Form of Placement Agency Agreement (Filed With SEC on November 1, 2024)
- Form of Placement Agent Warrant (Filed With SEC on November 1, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on November 1, 2024)
- Form of Common Stock Purchase Warrant (Filed With SEC on November 1, 2024)
- Clinical Trial Agreement dated as of June 10, 2024 between the Company and the Netherlands Cancer Institute (Filed With SEC on June 14, 2024)
- Consulting Agreement dated as of May 31, 2024 between the Company and Dr. Jan Schellens (Filed With SEC on June 5, 2024)
- Compensation Clawback Policy (Filed With SEC on March 19, 2024)
- Exclusive Patent License with NINDS and NCI (Filed With SEC on February 26, 2024)
- 2020 Stock Incentive Plan, as amended (Filed With SEC on November 28, 2023)
- Amendment No. 1 to Development Collaboration Agreement by and between Lixte Biotechnology Holdings, Inc and the Netherlands Cancer Institute, Amsterdam, and the Oncode Institute,... (Filed With SEC on November 9, 2023)
- Termination letter between H. Lee Moffitt Cancer Center and Research Institute, Inc. and the Company dated October 4, 2023 and effective as of September 30, 2023 (Filed With SEC on November 9, 2023)
- Amendment 2 to Development Collaboration Agreement (certain portions of this Exhibit have been omitted) (Filed With SEC on October 17, 2023)
- Employment Agreement as of September 26, 2023 between the Company and Bastiaan van der Baan (Filed With SEC on September 27, 2023)
- Securities Purchase Agreement (Filed With SEC on July 20, 2023)
- Form of Placement Agent Warrant (Filed With SEC on July 20, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on July 20, 2023)
- Form of Common Stock Purchase Warrant (Filed With SEC on July 20, 2023)
- Amendment to Contract between Lixte Biotechnology Holdings, Inc. and MRI Global effective April 17, 2022 (Filed With SEC on May 10, 2023)
- Second Amendment to Employment Agreement Between the Company and Eric Forman (Filed With SEC on March 29, 2023)
- Insider Trading Policy (Filed With SEC on March 29, 2023)
- Form of Placement Agents Warrant (Filed With SEC on April 15, 2022)
- Securities Purchase Agreement (Filed With SEC on April 15, 2022)
- Development Collaboration Agreement by and between Lixte Biotechnology Holdings, Inc. and the Netherlands Cancer Institute, Amsterdam, and Oncode Institute, Utrecht, entered into... (Filed With SEC on November 10, 2021)
- Sales Agreement dated as of September 20, 2021 between Lixte Biotechnology Holdings, Inc. and WestPark Capital, Inc (Filed With SEC on September 20, 2021)
- Amendment to Employment Agreement between the Company and Eric Forman (Filed With SEC on March 26, 2021)
- Securities Purchase Agreement (Filed With SEC on March 2, 2021)
- Form of Placement Agents Warrant (Filed With SEC on March 2, 2021)
- Underwriting Agreement, dated as of November 25, 2020, between the Company and WestPark Capital, Inc. and WallachBeth, LLC (Filed With SEC on November 27, 2020)
- Warrant Agency Agreement, dated as of November 25, 2020, between the Company and Computershare (Filed With SEC on November 27, 2020)
- Form of Public Warrant (Filed With SEC on November 27, 2020)
- Form of Warrant Agent Agreement (Filed With SEC on November 16, 2020)
- Form of Warrant included in Unit (Filed With SEC on November 16, 2020)
- Form of Underwriter Agreement (Filed With SEC on November 16, 2020)
- Form of Underwriter Agreement (Filed With SEC on October 13, 2020)
- Employment Agreement with Robert Weingarten (Filed With SEC on August 18, 2020)
- Master Service Agreement with Foundation of Angelman Syndrome Therapeutics FAST (Filed With SEC on August 18, 2020)
- Employment Agreement with Dr. James Miser (Filed With SEC on July 17, 2020)
- Employment Agreement with Eric Forman (Filed With SEC on July 17, 2020)
- Employment Agreement with Dr. John Kovach (Filed With SEC on July 17, 2020)
- Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan (Filed With SEC on July 17, 2020)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 25, 2020)
- Clinical Trial Research Agreement1 (Filed With SEC on August 6, 2019)
- Form of Warrant (Filed With SEC on December 5, 2018)
- Clinical Trial Research Agreement1 (Filed With SEC on August 23, 2018)
- Exclusive License Agreement (Filed With SEC on August 23, 2018)
- Consulting Agreement between Liberi Life Sciences Consultancy BV and Lixte Biotechnology Holdings, Inc. dated and effective as of April 2, 2018 (Filed With SEC on August 2, 2018)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on April 10, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 28, 2017)
- EXCLUSIVELICENSE AGREEMENT (Filed With SEC on December 30, 2015)
- ADVISORYAGREEMENT (Filed With SEC on November 10, 2015)
- STOCKOPTION AGREEMENT (Filed With SEC on November 10, 2015)
- WARRANT TO PURCHASE COMMON STOCK OF LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filed With SEC on September 18, 2015)
- WARRANT TO PURCHASE COMMON STOCK OF LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filed With SEC on September 18, 2015)
- CollaborationAgreement between the Company and BioPharmaWorks LLC (Filed With SEC on September 18, 2015)
- CERTIFICATEOF DESIGNATIONS SERIES A CONVERTIBLE PREFERRED STOCK OF LIXTE BIOTECHNOLOGY HOLDINGS, INC. (pursuant to Section 151 of the Delaware General Corporation Law) (Filed With SEC on March 18, 2015)
- ADVISORY AGREEMENT (Filed With SEC on March 21, 2014)
- SCIENTIFICADVISORY BOARD AGREEMENT (Filed With SEC on March 21, 2014)
- NATIONAL INSTITUTES OF HEALTH MATERIALS COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT (Filed With SEC on March 21, 2014)
- CONSULTINGAGREEMENT (Filed With SEC on November 12, 2009)
- PUBLICHEALTH SERVICE PATENTLICENSE AGREEMENT EXCLUSIVE COVERPAGE (Filed With SEC on March 31, 2009)
- AMENDMENT (Filed With SEC on May 14, 2008)
- EXHIBIT 10.1 (Filed With SEC on February 9, 2007)
- SERVICES AGREEMENT between LIXTE BIOTECHNOLOGY, INC. and Freestate of Bavaria Represented by UNIVERSITY OF REGENSBURG for its Institute of Pathology, Franz-Josef-Strauss-Alle 11,... (Filed With SEC on January 11, 2007)
- EXHIBIT 2.1 (Filed With SEC on July 7, 2006)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on June 8, 2006)
